These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 24761855

  • 1. Hypofractionated radiotherapy for breast cancers--preliminary results from a tertiary care center in eastern India.
    Nandi M, Mahata A, Mallick I, Achari R, Chatterjee S.
    Asian Pac J Cancer Prev; 2014; 15(6):2505-10. PubMed ID: 24761855
    [Abstract] [Full Text] [Related]

  • 2. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Lyczek J, Guinot JL, Dunst J, Miguelez CG, Slampa P, Allgäuer M, Lössl K, Polat B, Kovács G, Fischedick AR, Fietkau R, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Schlamann A, Pötter R, Gall C, Uter W, Strnad V, Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO).
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [Abstract] [Full Text] [Related]

  • 3. A Phase 2 Study of 2 Weeks of Adjuvant Whole Breast/Chest Wall and/or Regional Nodal Radiation Therapy for Patients With Breast Cancer.
    Yadav BS, Sharma SC.
    Int J Radiat Oncol Biol Phys; 2018 Mar 15; 100(4):874-881. PubMed ID: 29485066
    [Abstract] [Full Text] [Related]

  • 4. Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors.
    Ciammella P, Podgornii A, Galeandro M, Micera R, Ramundo D, Palmieri T, Cagni E, Iotti C.
    Radiat Oncol; 2014 Apr 24; 9():97. PubMed ID: 24762173
    [Abstract] [Full Text] [Related]

  • 5. Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.
    Scorsetti M, Alongi F, Fogliata A, Pentimalli S, Navarria P, Lobefalo F, Garcia-Etienne C, Clivio A, Cozzi L, Mancosu P, Nicolini G, Vanetti E, Eboli M, Rossetti C, Rubino A, Sagona A, Arcangeli S, Gatzemeier W, Masci G, Torrisi R, Testori A, Alloisio M, Santoro A, Tinterri C.
    Radiat Oncol; 2012 Aug 28; 7():145. PubMed ID: 22929062
    [Abstract] [Full Text] [Related]

  • 6. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
    Ahlawat S, Haffty BG, Goyal S, Kearney T, Kirstein L, Chen C, Moore DF, Khan AJ.
    Int J Radiat Oncol Biol Phys; 2016 Jan 01; 94(1):118-125. PubMed ID: 26700706
    [Abstract] [Full Text] [Related]

  • 7. Preoperative radiotherapy in breast cancer patients: 32 years of follow-up.
    Riet FG, Fayard F, Arriagada R, Santos MA, Bourgier C, Ferchiou M, Heymann S, Delaloge S, Mazouni C, Dunant A, Rivera S.
    Eur J Cancer; 2017 May 01; 76():45-51. PubMed ID: 28267657
    [Abstract] [Full Text] [Related]

  • 8. Hypofractionated radiotherapy for breast cancer patients treated by breast-conserving surgery: short-term morbidity and preliminary results.
    Plataniotis GA, Theofanopoulou MA, Sotiriadou K, Kyrgias G.
    Breast Cancer; 2010 May 01; 17(1):42-7. PubMed ID: 19350358
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
    Fastner G, Reitsamer R, Ziegler I, Zehentmayr F, Fussl C, Kopp P, Peintinger F, Greil R, Fischer T, Deutschmann H, Sedlmayer F.
    Int J Cancer; 2015 Mar 01; 136(5):1193-201. PubMed ID: 24995409
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant hypofractionated radiation therapy for breast cancer after conserving surgery.
    Livi L, Stefanacci M, Scoccianti S, Dicosmo D, Borghesi S, Nosi F, Simontacchi G, Mangoni M, Paiar F, Ponticelli P, Nori J, Chiavacci A, Biti GP.
    Clin Oncol (R Coll Radiol); 2007 Mar 01; 19(2):120-4. PubMed ID: 17355107
    [Abstract] [Full Text] [Related]

  • 14. A unique hypofractionated radiotherapy schedule with 51.3 Gy in 18 fractions three times per week for early breast cancer: outcomes including local control, acute and late skin toxicity.
    Vassilis K, Ioannis G, Anna Z, Christina A, Christos A, John K, Porfyrios K, Vassiliki G, John K.
    Breast Cancer; 2017 Mar 01; 24(2):263-270. PubMed ID: 27093861
    [Abstract] [Full Text] [Related]

  • 15. Intraoperative radiotherapy (IORT) as a boost in patients with early-stage breast cancer -- acute toxicity.
    Kraus-Tiefenbacher U, Bauer L, Kehrer T, Hermann B, Melchert F, Wenz F.
    Onkologie; 2006 Mar 01; 29(3):77-82. PubMed ID: 16514267
    [Abstract] [Full Text] [Related]

  • 16. Intensity modulated radiation therapy with simultaneous integrated boost in early breast cancer irradiation. Report of feasibility and preliminary toxicity.
    Fiorentino A, Mazzola R, Ricchetti F, Giaj Levra N, Fersino S, Naccarato S, Sicignano G, Ruggieri R, Di Paola G, Massocco A, Gori S, Alongi F.
    Cancer Radiother; 2015 Aug 01; 19(5):289-94. PubMed ID: 26206732
    [Abstract] [Full Text] [Related]

  • 17. A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects.
    Guenzi M, Vagge S, Azinwi NC, D'Alonzo A, Belgioia L, Garelli S, Gusinu M, Corvò R.
    Radiat Oncol; 2010 Nov 22; 5():111. PubMed ID: 21092219
    [Abstract] [Full Text] [Related]

  • 18. Weekly concomitant boost in adjuvant radiotherapy for patients with early breast cancer: preliminary results on feasibility.
    Corvò R, Giudici S, Maggio F, Bevegni M, Sampietro C, Lucido MR, Orsatti M.
    Tumori; 2008 Nov 22; 94(5):706-11. PubMed ID: 19112945
    [Abstract] [Full Text] [Related]

  • 19. Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre of India.
    Mondal D, Julka PK, Sharma DN, Jana M, Laviraj MA, Deo SV, Roy S, Guleria R, Rath GK.
    J Egypt Natl Canc Inst; 2017 Mar 22; 29(1):39-45. PubMed ID: 28343538
    [Abstract] [Full Text] [Related]

  • 20. Hypofractionated irradiation in elderly patients with breast cancer after breast conserving surgery and mastectomy : Analysis of 205 cases.
    Doré M, Cutuli B, Cellier P, Campion L, Le Blanc M.
    Radiat Oncol; 2015 Aug 04; 10():161. PubMed ID: 26238442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.